Global /India /Healthcare /Drug Manufacturers - General /VALIANTLAB

Valiant Laboratories Ltd.

VALIANTLAB

• NSE: VALIANTLAB • Delayed

78.95INR -3.3%

0.8362 USD

As of 20 June 2026, Valiant Laboratories Ltd. has a market cap of $46.98M USD, ranking #31034 globally and #2025 in India. It ranks #2803 in the Healthcare sector, and #979 in the Drug Manufacturers - General industry.

Global Rank

31034

Country Rank

2025

Sector Rank

2803

Industry Rank

979

Key Stats

Market Cap

$46.98MUSD

4.43B INR

Enterprise Value

$46.0MUSD

4.34B INR

Revenue (TTM)

$21.54MUSD

2.03B INR

EBITDA (TTM)

$400.68KUSD

37.83M INR

Net Income (TTM)

-$458.89KUSD

-43.31M INR

EBITDA Margin

1.9%

Profit Margin

-2.1%

PS Ratio

2.2

PB Ratio

1.4

EV/EBITDA

109.3

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Santosh Vora open_in_new

Employees

Founded

1980

Website

valiantlabs.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.3%	20%	52%	42%	-3.1%	17%	-17%	-55%	-55%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	VALIANTLAB Valiant Laboratories Ltd ISIN: INE0JWS01017 Shares Out.: Shares Outstanding: 54.313M¹ Shares Float: 13.624M² TV: TradingView: NSE: VALIANTLAB SA: Stock Analysis: NSE: VALIANTLAB YF: Yahoo Finance: VALIANTLAB.NS GF: Google Finance: NSE: VALIANTLAB BA: Barron's: VALIANTLAB MS: Morningstar: XNSE: VALIANTLAB	78.95 INR	TV: TradingView: NSE: VALIANTLAB SA: Stock Analysis: NSE: VALIANTLAB YF: Yahoo Finance: VALIANTLAB.NS GF: Google Finance: NSE: VALIANTLAB BA: Barron's: VALIANTLAB MS: Morningstar: XNSE: VALIANTLAB
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	543998 (VALIANTLAB) Valiant Laboratories Ltd ISIN: INE0JWS01017 TV: TradingView: BSE: VALIANTLAB SA: Stock Analysis: BOM: 543998 YF: Yahoo Finance: 543998.BO GF: Google Finance: BOM: 543998 BA: Barron's: 543998 MS: Morningstar: XBOM: 543998	78.85 INR	TV: TradingView: BSE: VALIANTLAB SA: Stock Analysis: BOM: 543998 YF: Yahoo Finance: 543998.BO GF: Google Finance: BOM: 543998 BA: Barron's: 543998 MS: Morningstar: XBOM: 543998

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Valiant Laboratories Ltd.

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 96K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 39K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 32K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 25K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 21K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 21K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 2M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 1M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 767K%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 677K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 606K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 583K%	15.1	United States

chevron_leftBack